Exosome-inspired plant vesicles sales will expand through 2036, with skin care holding 10.1% of the end use application segment in 2026. The market was valued at USD 59.10 billion in 2025 and is expected to be worth USD 237.98 billion by 2036, creating an incremental opportunity of USD 170.90 billion.